A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Saba Sile, MD
BioMarin Pharmaceutical
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Augusta, Georgia, United States
- Facility name not stated
Savannah, Georgia, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
Flint, Michigan, United States
- Facility name not stated
Hackensack, New Jersey, United States
- Facility name not stated
Chapel Hill, North Carolina, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Galveston, Texas, United States
- Facility name not stated
Norfolk, Virginia, United States
- Facility name not stated
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 31 Aug 2008
- Completion
- 30 Jun 2009
- Last update posted
- 25 Feb 2021
- Registered enrollment
- 32
- Registry id
- NCT00445978
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.